A method for the treatment of conditions associated with a need for inhibition of GSK-3, such as diabetes, dementias such as Alzheimer's disease and manic depression which method comprises the administration of a pharmaceutically effective, non-toxic amount of a compound of formula (I):
1
or a pharmaceutically acceptable derivative thereof, wherein:
R is hydrogen, alkyl, aryl, or aralkyl;
R
1
is hydrogen, alkyl, aralkyl, hydroxyalkyl or alkoxyalkyl;
R
2
is substituted or unsubstituted aryl or substituted or unsubstituted heterocyclyl;
R
3
is hydrogen, substituted or unsubstituted alkyl, cycloalkyl, alkoxyalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclyl or aralkyl wherein the aryl moiety is substituted or unsubstituted; or,
R
1
and R
3
together with the nitrogen to which they are attached form a single or fused, optionally substituted, saturated or unsaturated heterocylic ring;
to a human or non-human mammal in need thereof, and compounds of formula I.
Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
申请人:Chatterjee-Kishore Moitreyee
公开号:US20060252045A1
公开(公告)日:2006-11-09
The invention discloses compositions, compounds, apparatuses and methods of using them to study bone mineralization and identify agents that regulate bone mineralization. Methods of using bone mineralization gene profiles and signatures for compound screening and research are also disclosed. Reagents for modulating bone mineralization are provided for both therapeutic and research usage.
Acid cyclization of amino-substituted heterocycles. Synthesis of 1,3-dioxo- pyrrolo[3,4-c]- and thieno[3,4-c]isoquino- lines and cinnolines
作者:S. Yu. Zinchenko、R. A. Efimenko、S. Yu. Suikov、K. I. Kobrakov、S. L. Bogza
DOI:10.1007/s10593-009-0262-2
日期:2009.3
The reaction of 3-amino-4-(3,4-dimethoxyphenyl)maleimide and the methyl esters of 3-amino-4-(3,4-dimethoxyphenyl)-5-R-thiophene-2-carboxylic acids with carbonyl compounds and nitrous acid has been investigated. Dioxopyrrolo[3,4-c]- and thieno[3,4-c]isoquinolines and cinnolines were obtained.
PYRROLE-2,5-DIONES AS GSK-3 INHIBITORS
申请人:SMITHKLINE BEECHAM PLC
公开号:EP1119548A1
公开(公告)日:2001-08-01
METHODS AND MATERIALS FOR IDENTIFYING AGENTS WHICH MODULATE BONE REMODELING AND AGENTS IDENTIFIED THEREBY